These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


120 related items for PubMed ID: 7275853

  • 1. Substances derived from 4-de-N-methylfortimicin B.
    Kurath P, Tadanier J, Johnson P, Grampovnik D, Egan RS, Stanaszek RS, Cirovic M, Washburn WH, Leonard JE.
    J Antibiot (Tokyo); 1981 Jun; 34(6):691-700. PubMed ID: 7275853
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Chemical modification of fortimicins. III. preparation of N-substituted fortimicin A derivatives.
    Mochida K, Sato M, Yoshiie S, Mori Y, Shirahata K, Kitaura K.
    J Antibiot (Tokyo); 1981 May; 34(5):522-9. PubMed ID: 7275834
    [Abstract] [Full Text] [Related]

  • 6. 4-N-Aminoacylfortimicins E.
    Kurath P, Grampovnik D, Tadanier J, Martin JR, Egan RS, Stanaszek RS, Cirovic M, Washburn WH, Hill P, Dunnigan DA, Leonard JE, Johnson P, Goldstein AW.
    J Antibiot (Tokyo); 1979 Sep; 32(9):884-90. PubMed ID: 511780
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. 6'-N-methylfortimicins A and B and 6',6'-di-N-methylfortimicins A and B.
    Tadanier J, Dunnigan DA, Martin JR, Freiberg L, Cirovic M.
    J Antibiot (Tokyo); 1981 Feb; 34(2):193-201. PubMed ID: 7298511
    [Abstract] [Full Text] [Related]

  • 9. Lysinomicin, a new aminoglycoside antibiotic. II. Structure and stereochemistry.
    Kurath P, Rosenbrook W, Dunnigan DA, McAlpine JB, Egan RS, Stanaszek RS, Cirovic M, Mueller SL, Washburn WH.
    J Antibiot (Tokyo); 1984 Oct; 37(10):1130-43. PubMed ID: 6501087
    [Abstract] [Full Text] [Related]

  • 10. Chemical modification of fortimicins. IV. Preparation of 4,2'-Di-N-substituted fortimicin B derivatives.
    Sato M, Mochida K, Yoshiie S, Mori Y, Shirahata K, Kitaura K.
    J Antibiot (Tokyo); 1981 May; 34(5):530-5. PubMed ID: 7275835
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. synthesis of 2-deoxyfortimicins and 1-deamino-2-deoxy-2-epi-aminofortimicins via 2-O-methanesulfonylfortimicin B.
    Martin JR, Johnson P, Tadanier J, Goldstein AW.
    J Antibiot (Tokyo); 1980 Aug; 33(8):810-8. PubMed ID: 7429983
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Chemical modification of fortimicins. II. Selective protection of fortimicins A and B.
    Sato M, Mochida K, Mori Y, Shirahata K.
    J Antibiot (Tokyo); 1981 May; 34(5):513-21. PubMed ID: 7275833
    [Abstract] [Full Text] [Related]

  • 17. Fortimicin analogs via glycoside formation.
    Rosenbrook W, Fairgrieve JS.
    J Antibiot (Tokyo); 1981 Jun; 34(6):681-90. PubMed ID: 7275852
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Synthesis and antibacterial activity of novel neamine derivatives.
    Minowa N, Akiyama Y, Hiraiwa Y, Maebashi K, Usui T, Ikeda D.
    Bioorg Med Chem Lett; 2006 Dec 15; 16(24):6351-4. PubMed ID: 16997557
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.